| Drug Name | Defitelio (defibrotide sodium) |
|---|---|
| Drug Class | |
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Hematology
|
| Risk |
Defibrotide increases the risk of bleeding and should be withheld or stopped if significant bleeding occurs |
| Dear Healthcare provider letter DHPC |
|